Noninvasive Prenatal Testing By Analyzing Mother's Blood - Currently, prenatal diagnosis of genetic diseases and genetic monitoring of fetal development require invasive procedures. New data generated by Jill Maron and colleagues, at Tufts -- New England Medical Center, Boston, has indicated that it might be possible to perform these processes non-invasively.

In the study, it was shown that a common pattern of fetal mRNAs, the molecules that hold the "blueprints" for proteins, was detectable in the blood of pregnant women. After birth, these mRNAs were no longer detected or were detected at substantially lower levels.

These data have two important implications: first, the common pattern of fetal mRNAs found in the blood of the pregnant women could serve as a baseline to compare fetuses affected by various pathologic conditions; and second, monitoring specific fetal mRNAs in the blood of pregnant women could be used for prenatal diagnosis of genetic diseases.

Article: Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood

Note: This story has been adapted from a news release issued by Journal of Clinical Investigation.

Article based on information provided by: Journal of Clinical Investigation, Ann Arbor, Michigan U.S.A.
Adapted and published by:
Originally released on: September 26

Next Article: Black Patients With Asthma May Fare Worse Regardless Of Disease Severity
More Articles On: Pregnancy, Pediatric, Gynecology, Birth Defects, Hypertension, Womens Health,